Kavita Sharma, MD
Assistant Professor, Medicine
Biography
Dr. Kavita Sharma is a Weight Management Specialist at Boston Medical Center and Assistant Professor of Medicine in Endocrinology, Diabetes, Nutrition, and Weight Management at the Chobanian and Avedisian School of Medicine. She graduated from medical school in India and completed a residency in Internal Medicine from Cambridge Health Alliance, Boston, MA. While practicing as an Internist she found her passion for obesity and specialized nutrition therapy. This led to completion of a fellowship program at Brigham and Women’s Hospital/Harvard Medical School, Boston. She is board certified in Internal Medicine, Obesity Medicine and Nutrition Support. Her research interest includes Obesity Medicine, Hospital Malnutrition and Total Parenteral Nutrition (TPN) therapy. She enjoys working in an academic multidisciplinary setting, taking care of diverse patient population and currently serves as the Director of Nutrition Support Service at Boston Medical Center.
Education
- Netaji Subhash Chandra Bose Medical College, India, MBBS
Publications
- Published on 9/14/2024
Shah SJ, Sharma K, Borlaug BA, Butler J, Davies M, Kitzman DW, Petrie MC, Verma S, Patel S, Chinnakondepalli KM, Einfeldt MN, Jensen TJ, Rasmussen S, Asleh R, Ben-Gal T, Kosiborod MN. Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials. Eur Heart J. 2024 Sep 14; 45(35):3254-3269. PMID: 38739118.
Read at: PubMed - Published on 9/1/2024
Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Chang-Sheng M, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang S, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov L, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Kolkhof P, Viswanathan P. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2024 Sep 01. PMID: 39225278.
Read at: PubMed - Published on 7/25/2024
Meddeb M, Koleini N, Binek A, Keykhaei M, Darehgazani R, Kwon S, Aboaf C, Margulies KB, Bedi KC, Lehar M, Sharma K, Hahn VS, Van Eyk JE, Drachenberg CI, Kass DA. Myocardial ultrastructure of human heart failure with preserved ejection fraction. Nat Cardiovasc Res. 2024 Aug; 3(8):907-914. PMID: 39196036.
Read at: PubMed - Published on 6/26/2024
Kitzman DW, Lewis GD, Pandey A, Borlaug BA, Sauer AJ, Litwin SE, Sharma K, Jorkasky DK, Khan S, Shah SJ. A novel controlled metabolic accelerator for the treatment of obesity-related heart failure with preserved ejection fraction: Rationale and design of the Phase 2a HuMAIN trial. Eur J Heart Fail. 2024 Jun 26. PMID: 38924328.
Read at: PubMed - Published on 6/23/2024
Verma S, Butler J, Borlaug BA, Davies M, Kitzman DW, Shah SJ, Petrie MC, Barros E, Rönnbäck C, Vestergaard LS, Schou M, Ezekowitz JA, Sharma K, Patel S, Chinnakondepalli KM, Kosiborod MN. Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials. J Am Coll Cardiol. 2024 Aug 27; 84(9):773-785. PMID: 38913003.
Read at: PubMed - Published on 6/7/2024
Bermea KC, Lovell JP, Hays AG, Goerlich E, Vungarala S, Jani V, Shah SJ, Sharma K, Adamo L. A Machine Learning-Derived Score to Effectively Identify Heart Failure With Preserved Ejection Fraction. JACC Adv. 2024 Jul; 3(7):101040. PMID: 39130016.
Read at: PubMed - Published on 5/26/2024
Fudim M, Cyr DD, Ward JH, Hernandez AF, Lepage S, Morrow DA, Sharma K, Claggett BL, Starling RC, Velazquez EJ, Williamson KM, Desai AS, Zieroth S, Solomon SD, Braunwald E, Mentz RJ. Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial. J Card Fail. 2024 May 26. PMID: 38802053.
Read at: PubMed - Published on 5/13/2024
Petrie MC, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Shah SJ, Verma S, Jensen TJ, Einfeldt MN, Liisberg K, Perna E, Sharma K, Ezekowitz JA, Fu M, Melenovský V, Ito H, Lelonek M, Kosiborod MN. Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program. J Am Coll Cardiol. 2024 Jul 02; 84(1):27-40. PMID: 38819334.
Read at: PubMed - Published on 5/11/2024
Solomon SD, Ostrominski JW, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Ma CS, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesová E, Kang SM, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov LG, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Viswanathan P, McMurray JJV. Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial. Eur J Heart Fail. 2024 Jun; 26(6):1334-1346. PMID: 38733212.
Read at: PubMed - Published on 3/21/2024
Kim DW, Park JS, Sharma K, Velazquez A, Li L, Ostrominski JW, Tran T, Seitter Peréz RH, Shin JH. Qualitative evaluation of artificial intelligence-generated weight management diet plans. Front Nutr. 2024; 11:1374834. PMID: 38577160.
Read at: PubMed
View 32 more publications: View full profile at BUMC